Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

Completed · Phase 2

Conditions studied: Peripheral Nervous System Diseases, Chemotherapy-Induced Peripheral Neuropathy

In brief

This study will assess the safety and efficacy of Neotrofin in treating the peripheral neuropathy that results from chemotherapy for cancer.

Key facts

Study ID

NCT00041795

Run by

NeoTherapeutics

People needed

50

Starts

2002-01-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Alta Bates Comprehensive Cancer Center — Berkeley, California, United States
• Providence St. Joseph Medical Center — Burbank, California, United States
• Providence Holy Cross Medical Center — Mission Hills, California, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• NYU Medical Center — New York, New York, United States
• The Sarah Cannon Cancer Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.